PARVIGEN LIOFILIZADO Y DISOLVENTE PARA SUSPENSION INYECTABLE PARA PERROS
PARVIGEN LIOFILIZADO Y DISOLVENTE PARA SUSPENSION INYECTABLE PARA PERROS
Authorised
- Canine parvovirus, strain Cornell 780916, Live
Product identification
Medicine name:
PARVIGEN LIOFILIZADO Y DISOLVENTE PARA SUSPENSION INYECTABLE PARA PERROS
Active substance:
- Canine parvovirus, strain Cornell 780916, Live
Target species:
-
Dog
Route of administration:
-
Subcutaneous use
Product details
Active substance and strength:
-
Canine parvovirus, strain Cornell 780916, Live7.00/50% cell culture infectious dose1.00millilitre(s)
Pharmaceutical form:
-
Lyophilisate and solvent for suspension for injection
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QI07AD01
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Spain
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Full application - Known active substance (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Virbac Espana S.A.
Marketing authorisation date:
Manufacturing sites for batch release:
- Virbac
Responsible authority:
- Spanish Agency Of Medicines And Medical Devices
Authorisation number:
- 3238 ESP
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it
in another language below.
Spanish (PDF)
Published on: 15/04/2025
Package Leaflet
This document does not exist in this language (English). You can find it
in another language below.
Spanish (PDF)
Published on: 15/04/2025
Labelling
This document does not exist in this language (English). You can find it
in another language below.
Spanish (PDF)
Published on: 15/04/2025
